Interstitial pneumonia in a patient treated with TAS-102 for metastatic colorectal cancer: a case report

BACKGROUND: TAS-102, a new treatment option for patients with metastatic colorectal cancer that is refractory or intolerant to standard therapies, has been improving survival with acceptable tolerability and adverse events. Adverse hematological events associated with TAS-102 treatment were extensiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamei, Hideki, Ishibashi, Nobuya, Tanigawa, Masahiko, Yamaguchi, Keizo, Uchida, Masafumi, Akagi, Yoshito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094012/
https://www.ncbi.nlm.nih.gov/pubmed/27809894
http://dx.doi.org/10.1186/s13256-016-1097-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094012/
https://www.ncbi.nlm.nih.gov/pubmed/27809894
http://dx.doi.org/10.1186/s13256-016-1097-y

Ejemplares similares